Masimo’s planned buyout of Lidco could help expand its footprint into the US.
There have been few acquisitions in the hemodynamics monitoring space recently, but Masimo Corp.’s $40.3m cash offer for the UK-based LiDCO Group Plc is a good fit, according to BTIG analyst Marie Thibault.
“Lidco’s technology is complementary to Masimo’s Pleith Variabilty Index and SpHb total hemoglobin monitoring parameters, so should add to clinician...
Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.
Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.
Faction Imaging has come out of stealth mode following six years of research and development studying medical imaging workflows in India, Japan and the US.
The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.
Legal experts warn, however, that new Mexican procurement rules are discriminatory and could be challenged in the courts.
It’s no secret that Marty Makary and Robert F. Kennedy Jr. have a different take on user fees, with Makary viewing them as a funding necessity and Kennedy as a corrupting influence. But will they find a way to strike a balance during the next MDUFA reauthorization talks so each can claim victory?
Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.
